Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,221,528
  • Shares Outstanding, K 47,703
  • Annual Sales, $ 294,010 K
  • Annual Income, $ -49,590 K
  • 60-Month Beta 1.26
  • Price/Sales 7.40
  • Price/Cash Flow N/A
  • Price/Book 3.94
Trade GKOS with:

Options Overview Details

View History
  • Implied Volatility 41.91% ( -4.47%)
  • Historical Volatility 47.45%
  • IV Percentile 2%
  • IV Rank 8.67%
  • IV High 82.45% on 05/09/22
  • IV Low 38.06% on 11/22/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 223
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 10,632
  • Open Int (30-Day) 11,681

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.56
  • Number of Estimates 7
  • High Estimate -0.44
  • Low Estimate -0.66
  • Prior Year -0.31
  • Growth Rate Est. (year over year) -80.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.72 +8.82%
on 11/30/22
55.93 -13.00%
on 11/02/22
-5.92 (-10.85%)
since 11/01/22
3-Month
44.72 +8.82%
on 11/30/22
60.92 -20.12%
on 09/07/22
-0.18 (-0.37%)
since 09/01/22
52-Week
33.33 +45.99%
on 05/10/22
64.49 -24.55%
on 04/08/22
+6.93 (+16.61%)
since 12/01/21

Most Recent Stories

More News
Here's Why You Should Retain Glaukos (GKOS) in Your Portfolio

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

MCK : 379.72 (-0.51%)
AMN : 122.15 (-1.25%)
GKOS : 48.66 (+4.49%)
LNTH : 61.25 (-1.34%)
Here's Why Glaukos (GKOS) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Glaukos (GKOS), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions,...

GKOS : 48.66 (+4.49%)
Glaukos Announces Participation in the Stephens Annual Investment Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 48.66 (+4.49%)
Glaukos (GKOS) Beats on Q3 Earnings, Tightens Sales View

Glaukos' (GKOS) Q3 revenues fall year over year but beat estimates. Lower revenues along with higher expenses hurt margins.

MMSI : 72.52 (+0.72%)
GKOS : 48.66 (+4.49%)
MEDP : 215.54 (+2.69%)
ELV : 525.25 (-1.44%)
Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates

Glaukos (GKOS) delivered earnings and revenue surprises of 15.09% and 4.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

GKOS : 48.66 (+4.49%)
STIM : 6.20 (-1.27%)
Glaukos: Q3 Earnings Snapshot

Glaukos: Q3 Earnings Snapshot

GKOS : 48.66 (+4.49%)
Glaukos Corporation Announces Third Quarter 2022 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 48.66 (+4.49%)
Si-Bone (SIBN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SIBN : 12.68 (+3.26%)
GKOS : 48.66 (+4.49%)
The Zacks Analyst Blog Highlights Nevro, Masimo, Abiomed and Glaukos

Nevro, Masimo, Abiomed and Glaukos are part of the Zacks top Analyst Blog.

MASI : 145.74 (+0.55%)
ABMD : 377.44 (-0.09%)
NVRO : 47.90 (+2.55%)
GKOS : 48.66 (+4.49%)
4 MedTech Stocks Set to Outpace Q3 Earnings Estimates

Let us take a look at some MedTech stocks, NVRO, MASI, ABMD and GKOS, which are poised to beat on third-quarter earnings.

MASI : 145.74 (+0.55%)
ABMD : 377.44 (-0.09%)
NVRO : 47.90 (+2.55%)
GKOS : 48.66 (+4.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an...

See More

Key Turning Points

3rd Resistance Point 52.17
2nd Resistance Point 50.70
1st Resistance Point 49.68
Last Price 48.66
1st Support Level 47.18
2nd Support Level 45.71
3rd Support Level 44.69

See More

52-Week High 64.49
Fibonacci 61.8% 52.59
Fibonacci 50% 48.91
Last Price 48.66
Fibonacci 38.2% 45.23
52-Week Low 33.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar